Author

Kana Hasegawa

University Health NetworkORCID 0000-0002-5318-9690Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Brian D. BurtiD· 1 shared Dalam LyiD· 1 shared Dong-Hoon HaniD· 1 shared Evey Y. F. ZhengiD· 1 shared Fumie IharaiD· 1 shared Kayoko SasoiD· 1 shared Marcus Otho ButleriD· 1 shared Mark David MindeniD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Brian D. BurtORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Exploiting HLA-II Promiscuity via Peptide Terminal Overhang Recognition for Pan-Allelic and Tumor-Selective AML Immunotherapy

Saori Fukao, Evey Y. F. Zheng, Fumie Ihara, Yukiko Matsunaga, Yota Ohashi, Dong-Hoon Han, Xinyu Wei, Kana Hasegawa, Brian D. Burt, Kayoko Saso, Dalam Ly, Marcus Otho Butler, Mark David Minden, Yuki Kagoya, Naoto Hirano

This paper identifies an MPO-derived epitope promiscuously presented by HLA-II molecules and develops a pan-allelic antibody that selectively targets AML cells while sparing normal myeloid cells.

bioRxiv · Mar 3, 2026 · PreprintImmunology